OpenVSafe by OpenVAERS
Search V-safe

UQS-10225-75750

3 vaccinations 2 coded responses 26 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
923 / CA
Registered
2021-06-11
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-11
    Registered in v-safe
  2. 2021-06-11
    Dose 1 — Pfizer-BioNTech
  3. 2021-06-11
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-06-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-06-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-06-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-06-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-06-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-06-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-06-18
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-06-25
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-07-02
    Dose 2 — Pfizer-BioNTech
  13. 2021-07-02
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  14. 2021-07-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pyrexia — Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Fever
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-07-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  16. 2021-07-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-07-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-07-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-07-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-07-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-07-16
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-07-23
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-07-30
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-08-06
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-08-13
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-10-01
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-12-31
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-01-08
    Dose 3 — Pfizer-BioNTech
  29. 2022-07-11
    Survey response — 6 months, dose 3
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Two basic colds
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-07-11
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  31. 2022-07-12
  32. 2023-01-08
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-06-11Pfizer-BioNTech
22021-07-02Pfizer-BioNTech No
32022-01-08Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-07-11 Unsuccessful

Free text

Release 9 — days 1–6 daily, dose 2

2021-07-03

Systemic reaction (other): Fever

Release 12 — 6 months, dose 3

2022-07-11

Symptoms: Two basic colds

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SROPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…